An evaluation of factors associated with QTc-Interval prolongation in patients receiving propofol.

被引：0
|
作者：
Scalese, Michael [1 ]
Herring, Holly [1 ]
Rathbun, R. Chris [2 ]
Skrepnek, Grant [1 ]
Ripley, Toni [1 ]
机构：
[1] Univ Oklahoma, Coll Pharm, Oklahoma City, OK USA
[2] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Clin & Adm Sci, Oklahoma City, OK 73190 USA
来源：
PHARMACOTHERAPY | 2014年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
28
引用
收藏
页码：E186 / E186
页数：1
相关论文
共 50 条
  • [1] Evaluation of QTc-Interval Prolongation and Arrhythmogenic Indices and Associated Factors in Patients With COVID-19
    Eslami, Vahid
    Fesharaki, Mehrdad Jafari
    Shirini, Dorsa
    Gharaei, Babak
    Khave, Laya Jalilian
    Hassanzadeh, Taha
    Abdi, Saeed
    Pirsalehi, Ali
    Sanadgol, Ghazal
    [J]. IRANIAN HEART JOURNAL, 2022, 23 (03): : 77 - 87
  • [2] The prolongation of QTc-interval by thioridazine
    Sachdev, P
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2001, 35 (06): : 857 - 858
  • [3] Ventricular Ectopy and QTc-Interval Prolongation Associated with Dronedarone Therapy
    Gonzalez, Jaime E.
    Sauer, William H.
    Krantz, Mori J.
    [J]. PHARMACOTHERAPY, 2013, 33 (10): : E179 - E181
  • [4] EVALUATION OF AZITHROMYCIN ADMINISTRATION AND QTC-INTERVAL PROLONGATION IN THE CRITICALLY ILL
    Fiorvento, Anna
    Park, Linda
    Al Shelli, Ihab
    Mostafa, Ashraf
    Pusnik, Maria
    [J]. CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [5] QTc-interval prolongation and increased risk of sudden cardiac death associated with hydroxychloroquine
    Ahmadizar, Fariba
    Soroush, Negin
    Ikram, M. Arfan
    Kors, Jan A.
    Kavousi, Maryam
    Stricker, Bruno H.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 28 (17) : 1875 - 1882
  • [6] Information on QTc-Interval Prolongation in the Summary of Product Characteristics
    Warnier, Miriam J.
    Holtkamp, Frank A.
    Rutten, Frans H.
    Hoes, Arno W.
    de Boer, Anthonius
    Mol, Peter G. M.
    De Bruin, Marie L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 248 - 249
  • [7] Tramadol Induced QTc-Interval Prolongation: Prevalence, Clinical Factors and Correlation to Plasma Concentrations
    Keller, Guillermo A.
    Etchegoyen, Maria C. V.
    Fernandez, Nicolas
    Olivera, Nancy M.
    Quiroga, Patricia N.
    Belloso, Waldo H.
    Diez, Roberto A.
    Di Girolamo, Guillermo
    [J]. CURRENT DRUG SAFETY, 2016, 11 (03) : 206 - 214
  • [8] The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
    Sinkeler, F. S.
    Berger, F. A.
    Muntinga, H. J.
    Jansen, M. M. P. M.
    [J]. NETHERLANDS HEART JOURNAL, 2020, 28 (7-8) : 418 - 423
  • [9] The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
    F. S. Sinkeler
    F. A. Berger
    H. J. Muntinga
    M. M. P. M. Jansen
    [J]. Netherlands Heart Journal, 2020, 28 : 418 - 423
  • [10] Translating the gap in the evaluation of drug-induced QTc-interval prolongation from in vivo to the clinic
    Dubois, Vincent F. S.
    van der Graaf, Piet
    Leishman, Derek
    Gallacher, David
    McMahon, Nick
    Visser, Sandra
    Danhof, Meindert
    Della Pasqua, Oscar
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2014, 70 (03) : 324 - 324
12345